Bobbi Coffin, joined HepQuant’s Business Advisory Board in April 2022 with more than 25 years of success in clinical diagnostics, including commercialization strategies through strategic marketing, sales and business development.

Ms. Coffin currently serves as Chief Growth Officer of Bolder, Colorado-based Biodesix, a medical diagnostics company where she has held multiple marketing management roles since July 2015, including Chief Marketing Officer.

Prior to joining Biodesix, Ms. Coffin served as Senior Vice President of Commercial Marketing and Strategy at Exact Sciences, a molecular diagnostics company with a focus on the early detection and prevention of colorectal cancer. From 2007 to 2013, Ms. Coffin was Vice President of Marketing at Precision Therapeutics, and from 1999 to 2006, she held the position of Senior Director of Marketing at Cytyc Corporation (now Hologic).

Additionally, Ms. Coffin served as an executive board member for multiple national advocacy and society groups, including the National Comprehensive Cancer Network Corporate Counsel (NCCN), the Society of GYN Oncology (SGO) Industry Board, and the Colon Cancer Foundation. She currently serves on the executive committee and Board of Directors for the Colorado Bioscience Association. Ms. Coffin holds a B.S. from the College of Business and Economics and the Perley Isaac Reed School of Journalism, both completed at West Virginia University.